Target intelligence / Profile preview

Adenosine deaminase tRNA-specific 2 (ADAT2)

Target
ADAT2
Molecular classification
Enzyme, Deaminase, RNA-modifying enzyme
01

Overview

Adenosine deaminase tRNA-specific 2 (ADAT2) is an enzyme that functions as a catalytic subunit of the tRNA adenosine deaminase complex, responsible for converting adenosine to inosine at the wobble position (position 34) of various tRNAs[1][3][6][8]. This post-transcriptional modification expands the decoding capacity of tRNAs and is essential for accurate protein synthesis. In eukaryotes, ADAT2 forms a heterodimer with ADAT3 to achieve substrate recognition and catalytic activity[8]. Disruption of ADAT2 activity in model organisms leads to severe defects in cell growth and viability, highlighting its essential biological role[2]. Diseases associated with variants in ADAT2 include neurodevelopmental disorders and primary ciliary dyskinesia[1]. There are no known drugs that specifically target this enzyme, nor is it currently a routine clinical biomarker.

Other names
tRNA-specific adenosine deaminase 2DEADC1dJ20N2.1TAD2Deaminase domain-containing protein 1tRNA-specific adenosine-34 deaminase subunit ADAT2dJ20N2adenosine deaminase, tRNA-specific 2
02

Mechanism of action

Deaminates adenosine to inosine at position 34 in tRNA anticodons, thereby modifying the genetic decoding properties of tRNA[1][6][8]

03

Biological functions

tRNA adenosine-to-inosine (A-to-I) editing at position 34 (wobble position) of tRNAtRNA processing and modificationRNA editing
04

Disease associations

Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic faciesPrimary ciliary dyskinesiaOther (potential essential cellular functions suggested by model organism lethality)[1]
05

Safety considerations

Essential for cell viability; inhibition or loss of function leads to deficiency states, including severe neurodevelopmental disorders and impaired cell growth[1][2]

Beyond the preview

Go deeper on Adenosine deaminase tRNA-specific 2 (ADAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenosine deaminase tRNA-specific 2 (ADAT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call